-
RadiumBall
- Master | Next Rank: 500 Posts
- Posts: 132
- Joined: Thu Dec 02, 2010 2:49 am
- Thanked: 5 times
Research and development partnerships between investment funds and pharmaceutical corporations are experiencing considerable growth worldwide, even though products developed jointly by two or more corporations are less profitable than products developed by a single corporation. The advantage of research and development partnerships is that such arrangements may allow pharmaceutical firms to create successful products that would otherwise be too costly to develop.
Which of the following is information provided by the passage above?
(A) Product development is too costly for a single corporation to fund without research and development partnerships.
(B) Product development partnerships between pharmaceutical corporations and investment funds are more common now than they were in the recent past.
(C) Product development partnerships lead to products of higher quality.
(D) Joint research ventures between pharmaceutical corporations and investment funds produce exclusively costly products.
(E) Joint research ventures between pharmaceutical corporations and investment funds primarily benefit the investment funds.
Which of the following is information provided by the passage above?
(A) Product development is too costly for a single corporation to fund without research and development partnerships.
(B) Product development partnerships between pharmaceutical corporations and investment funds are more common now than they were in the recent past.
(C) Product development partnerships lead to products of higher quality.
(D) Joint research ventures between pharmaceutical corporations and investment funds produce exclusively costly products.
(E) Joint research ventures between pharmaceutical corporations and investment funds primarily benefit the investment funds.












